[23 cases of severe bullous dermatitis medicamentosa with epidermolysis].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000927:Anticonvulsants / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003228:Conjunctiva; D003692:Delayed-Action Preparations; D003875:Drug Eruptions / Q000473:pathology; D004820:Epidermolysis Bullosa / Q000139:chemically induced*; D005128:Eye Diseases; D005260:Female; D006801:Humans; D007223:Infant; D008171:Lung Diseases; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases; D009336:Necrosis / Q000473:pathology; D011379:Prognosis; D013449:Sulfonamides / Q000009:adverse effects*
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D003692:Delayed-Action Preparations; D013449:Sulfonamides
23 toxidermies bulleuses graves avec épidermolyse.